Fatty liver or Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting one in three adults globally, is a ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

“KPop Demon Hunters” made me sigh with relief: Hybrids, mash-ups, whatever you want to call it, are no longer a freak show ...

High rye bourbons stole the show at BTI 2025, with 11 Gold Medals. Bold, spicy, and complex, these whiskeys prove why ...

The 79th Independence Day was celebrated with great joy and enthusiasm at Udupi City Centre Mall on Friday Aug 15. The flag ...

Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver ...

Plainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first and ...

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug ...

Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

The new approval allows the GLP-1 to be used to treat adults with the liver disease metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring. Wegovy is the first GLP-1 to receive ...

Amateur fossil hunter Ross Dullard, who found the partial skull, says he will celebrate with a whale-themed party, marking ...

Yankees can mash, but playoffs will expose run prevention weakness again originally appeared on Athlon Sports. The Yankees ...